loading

Finanzdaten der Biocryst Pharmaceuticals Inc-Aktie (BCRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
0.69%
92.76
93.40 86.74 82.49 68.78
Cost Of Revenue
18.75%
1.265
1.557 1.099 0.894 0.931
Gross Profit
0.38%
91.50
91.84 85.64 81.60 67.85
Operating Expenses
21.21%
105.98
134.51 97.56 102.30 96.26
Interest Income/Expense
0.31%
24.51
24.58 27.34 28.91 27.40
Benefits Costs and Expenses
18.39%
127.78
156.56 122.56 157.08 121.44
Costs And Expenses
21.18%
107.25
136.07 98.66 103.19 97.19
Operating Income/Loss
66.05%
-14.49
-42.67 -11.92 -20.70 -28.41
Income/Loss From Continuing Operations Before Tax
44.56%
-35.01
-63.16 -35.82 -74.59 -52.66
Income Tax Expense/Benefit
125.51%
0.365
-1.431 0.33 0.74 0.671
Income/Loss From Continuing Operations After Tax
42.69%
-35.38
-61.73 -36.15 -75.33 -53.33
Net Income/Loss
42.69%
-35.38
-61.73 -36.15 -75.33 -53.33
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
6,541%
206.06
3.103 189.64 189.12 188.51
Diluted Average Shares
6,541%
206.06
3.103 189.64 189.12 188.51
Basic Earnings Per Share
45.16%
-0.17
-0.31 -0.19 -0.40 -0.28
Diluted Earnings Per Share
45.16%
-0.17
-0.31 -0.19 -0.40 -0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):